Mesadon 400 (Mesalazine Delayed-Release (400mg)

Mesadon-400 contains Mesalazine (400 mg) in a delayed-release formulation specifically designed to treat inflammatory bowel diseases including ulcerative colitis and Crohn’s disease. This anti-inflammatory medication works by targeting the inflamed areas of the gastrointestinal tract helping to reduce symptoms such as abdominal pain and diarrhea. The delayed-release feature ensures that Mesalazine is released in the intestines maximizing its therapeutic effect and enhancing patient compliance.